233 related articles for article (PubMed ID: 24424347)
41. Comparison of the antimicrobial effects of chlorine, silver ion, and tobramycin on biofilm.
Kim J; Pitts B; Stewart PS; Camper A; Yoon J
Antimicrob Agents Chemother; 2008 Apr; 52(4):1446-53. PubMed ID: 18195062
[TBL] [Abstract][Full Text] [Related]
42. Disrupting the mixed-species biofilm of Klebsiella pneumoniae B5055 and Pseudomonas aeruginosa PAO using bacteriophages alone or in combination with xylitol.
Chhibber S; Bansal S; Kaur S
Microbiology (Reading); 2015 Jul; 161(7):1369-77. PubMed ID: 25922418
[TBL] [Abstract][Full Text] [Related]
43. Spatial variations in growth rate within Klebsiella pneumoniae colonies and biofilm.
Wentland EJ; Stewart PS; Huang CT; McFeters GA
Biotechnol Prog; 1996; 12(3):316-21. PubMed ID: 8652119
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and characterization of the antibacterial potential of ZnO nanoparticles against extended-spectrum β-lactamases-producing Escherichia coli and Klebsiella pneumoniae isolated from a tertiary care hospital of North India.
Ansari MA; Khan HM; Khan AA; Sultan A; Azam A
Appl Microbiol Biotechnol; 2012 Apr; 94(2):467-77. PubMed ID: 22159886
[TBL] [Abstract][Full Text] [Related]
45. Pentadecanoic acid against Candida albicans-Klebsiella pneumoniae biofilm: towards the development of an anti-biofilm coating to prevent polymicrobial infections.
Galdiero E; Ricciardelli A; D'Angelo C; de Alteriis E; Maione A; Albarano L; Casillo A; Corsaro MM; Tutino ML; Parrilli E
Res Microbiol; 2021; 172(7-8):103880. PubMed ID: 34563667
[TBL] [Abstract][Full Text] [Related]
46. Effects of the twin-arginine translocase on the structure and antimicrobial susceptibility of Escherichia coli biofilms.
Harrison JJ; Ceri H; Badry EA; Roper NJ; Tomlin KL; Turner RJ
Can J Microbiol; 2005 Aug; 51(8):671-83. PubMed ID: 16234865
[TBL] [Abstract][Full Text] [Related]
47. [Feature and significance of bacterial biofilm formation in middle-ear mucosa in the rat model of acute otitis media].
Ke ZY; Yang MB; Gong TG; Liu M
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Mar; 46(3):220-4. PubMed ID: 21575414
[TBL] [Abstract][Full Text] [Related]
48. Evaluation of MBEC™-HTP biofilm model for studies of implant associated infections.
Coraça-Hubér DC; Fille M; Hausdorfer J; Pfaller K; Nogler M
J Orthop Res; 2012 Jul; 30(7):1176-80. PubMed ID: 22228044
[TBL] [Abstract][Full Text] [Related]
49. Antimicrobial efficacy of chlorhexidine against bacteria in biofilms at different stages of development.
Shen Y; Stojicic S; Haapasalo M
J Endod; 2011 May; 37(5):657-61. PubMed ID: 21496666
[TBL] [Abstract][Full Text] [Related]
50. Nutrient dispersion enhances conventional antibiotic activity against Pseudomonas aeruginosa biofilms.
Sommerfeld Ross S; Fiegel J
Int J Antimicrob Agents; 2012 Aug; 40(2):177-81. PubMed ID: 22727773
[TBL] [Abstract][Full Text] [Related]
51. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
52. Changes in serum sensitivity and hydrophobicity in a clinical isolate of Klebsiella pneumoniae treated with subinhibitory concentrations of aminoglycosides.
Hostacká A
Zentralbl Bakteriol; 1998 Dec; 288(4):519-26. PubMed ID: 9987190
[TBL] [Abstract][Full Text] [Related]
53. Assessment of antimicrobial combinations for Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.
Hirsch EB; Guo B; Chang KT; Cao H; Ledesma KR; Singh M; Tam VH
J Infect Dis; 2013 Mar; 207(5):786-93. PubMed ID: 23242537
[TBL] [Abstract][Full Text] [Related]
54. BioTimer Assay, a new method for counting Staphylococcus spp. in biofilm without sample manipulation applied to evaluate antibiotic susceptibility of biofilm.
Pantanella F; Valenti P; Frioni A; Natalizi T; Coltella L; Berlutti F
J Microbiol Methods; 2008 Dec; 75(3):478-84. PubMed ID: 18721833
[TBL] [Abstract][Full Text] [Related]
55. Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.
Sauer K; Steczko J; Ash SR
J Antimicrob Chemother; 2009 May; 63(5):937-45. PubMed ID: 19282330
[TBL] [Abstract][Full Text] [Related]
56. In vitro and in vivo evaluation of DNase I in reinstating antibiotic efficacy against Klebsiella pneumoniae biofilms.
Sharma A; Rishi P; Singh R
Pathog Dis; 2023 Jan; 81():. PubMed ID: 36633541
[TBL] [Abstract][Full Text] [Related]
57. The role and relationship with efflux pump of biofilm formation in Klebsiella pneumoniae.
Tang M; Wei X; Wan X; Ding Z; Ding Y; Liu J
Microb Pathog; 2020 Oct; 147():104244. PubMed ID: 32437832
[TBL] [Abstract][Full Text] [Related]
58. Characterization of biofilms in different clinical M serotypes of Streptococcus pyogenes.
Thenmozhi R; Balaji K; Kumar R; Rao TS; Pandian SK
J Basic Microbiol; 2011 Apr; 51(2):196-204. PubMed ID: 21298675
[TBL] [Abstract][Full Text] [Related]
59. Nonclassical Biofilms Induced by DNA Breaks in Klebsiella pneumoniae.
Liu Y; Pan C; Ye L; Si Y; Bi C; Hua X; Yu Y; Zhu L; Wang H
mSphere; 2020 Jun; 5(3):. PubMed ID: 32522779
[TBL] [Abstract][Full Text] [Related]
60. Biofilm inhibitory effect of chlorhexidine conjugated gold nanoparticles against Klebsiella pneumoniae.
Ahmed A; Khan AK; Anwar A; Ali SA; Shah MR
Microb Pathog; 2016 Sep; 98():50-6. PubMed ID: 27321770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
